GSK vet named CEO of Chi­na CAR-T JV with Kite; Co­herus fights back against Am­gen claims it stole trade se­crets

→ Richard Wang, the for­mer site chief for GSK in Shang­hai, is tak­ing the CEO’s job at Fo­s­un Kite, a joint ven­ture es­tab­lished by Kite Phar­ma and Shang­hai Fo­s­un to ad­vance Kite’s CAR-T $KITE to the mar­ket.

→Am­gen $AMGN has filed a law­suit against Co­herus Bio­Sciences $CHRS claim­ing theft of trade se­crets, ac­cord­ing to a state­ment from the biotech. And the Red­wood City, CA-based Co­herus says it plans to de­fend it­self vig­or­ous­ly, adding that Am­gen is sole­ly in­ter­est­ed in fend­ing off com­pe­ti­tion to peg­fil­gras­tim by mount­ing a de­lay­ing ac­tion in state court. “Co­herus re­mains com­mit­ted to the im­por­tant goal of bring­ing much-need­ed biosim­i­lar drugs to the mar­ket­place,” said CEO Den­ny Lan­fear in a state­ment. “We are con­fi­dent that we will pre­vail in this ac­tion and achieve our goals of in­creas­ing pa­tient ac­cess, in­tro­duc­ing com­pe­ti­tion and of­fer­ing biosim­i­lar prod­ucts at prices com­pet­i­tive with and low­er than those main­tained by Am­gen and oth­er large phar­ma­ceu­ti­cal com­pa­nies.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.